A meta-analysis of randomized controlled trials. J Hypertens 2010; 28: 1366 1372. references 391. Bulpitt CJ, Beckett NS, Cooke J et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409 2417. 392. Gong L, Zhang W, Zhu Y et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237 1245. 393. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31: 2115 2127. 394. Ogihara T, Saruta T, Rakugi H et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010; 56: 196 202. 395. Aronow WS, Fleg JL, Pepine CJ et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 2011; 5: 259 352. 396. MacGregor MS, Taal MW. Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKD. Nephron Clin Pract 2011; 118 (Suppl 1): c71 c100. 397. Moser M, Cushman WC, Ziegler MG. The treatment of hypertension in the elderly. J Clin Hypertens (Greenwich) 2008; 10: 58 68. 398. Menon V, Katz R, Mukamal K et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant 2010; 25: 3301 3307. 399. Soni RK, Weisbord SD, Unruh ML. Health-related quality of life outcomes in chronic kidney disease. 